Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

T. K. Owonikoko | Researchclopedia

Back to researchers

T. K. Owonikoko

University of Maryland, Baltimore

36

Works

186

Citations

9

h-index

8

i10-index

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers

Affiliations

University of Maryland, Baltimore2024–2025

Memorial Sloan Kettering Cancer Center2017–2018

Emory University2014–2021

University of Pittsburgh2006–2006

University of California, San Francisco2017–2017

Top Works

Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005

Kyndra S. Higgins,Chengping Hu,et al.

202448 citations

Lung Cancer Diagnosis and Treatment

Cancer therapeutics and mechanisms

Phase II study of RAD001 (Everolimus) in previously treated small cell lung cancer (SCLC)

T. K. Owonikoko,R. G. Stoller,et al.

200818 citations

Randomized phase 2 study of investigational aurora A kinase (AAK) inhibitor alisertib (MLN8237) + paclitaxel (P) vs placebo + P as second line therapy for small-cell lung cancer (SCLC)

T. K. Owonikoko,K. Nackaerts,et al.

201616 citations

Abstract PD3-13: Phase 1 study of CB-839, a first-in-class oral inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer

Kevin Kalinsky,JJ Harding,et al.

201813 citations

Comparison of survival for non-small cell lung cancer (NSCLC) between premenopausal and postmenopausal women: An analysis of the National Surveillance, Epidemiology and End Results (SEER) Database

Ana B. Oton,Chandra P. Belani,et al.

200612 citations

Phase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data

T. K. Owonikoko,K. Papadopoulos,et al.

201811 citations

Lung cancer in patients ≥ 80 years of age: Analysis of the national surveillance, epidemiology and end results (SEER) database

T. K. Owonikoko,Chandra P. Belani,et al.

200611 citations

Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)

Funda Meric‐Bernstam,Nizar M. Tannir,et al.

201610 citations

OA13.02 Two Novel Immunotherapy Agents Targeting DLL3 in SCLC: Trials in Progress of AMG 757 and AMG 119

T. K. Owonikoko,M. Damiette Smit,et al.

20189 citations